However, mRNA expression of BRDT in serous and endometrioid cancer patients revealed no any association with OS in ovarian cancer, HR= 0.89 (0.76 - 1.03), P = 0.12 (Figure 6B); HR= 0 (0 - inf), P = 0.092 (Figure 6C), respectively. This evidence concerns the gene BRDT and ovarian cancer.